Park Carolyn J, Vasu Sujethra, Urbain Jean L, Triozzi Pierre L, Pokharel Yashashwi
Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Section on Cardiovascular Medicine, Department of Internal Medicine and the Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
JACC Case Rep. 2022 Oct 19;4(20):1363-1365. doi: 10.1016/j.jaccas.2022.09.002.
We describe a first suspected case of fibrosing mediastinitis following anti-programmed death (PD)-1 therapy, pembrolizumab. Multimodality imaging, including cardiac magnetic resonance imaging, and a multidisciplinary team approach were integral to the diagnosis. If further substantiated, systematic surveillance after anti-PD-1 therapy for fibrosing mediastinitis may be warranted. ().
我们描述了首例怀疑为抗程序性死亡(PD)-1治疗药物帕博利珠单抗引发的纵隔纤维化病例。包括心脏磁共振成像在内的多模态成像以及多学科团队协作方法对诊断至关重要。如果得到进一步证实,抗PD-1治疗后对纵隔纤维化进行系统监测可能是必要的。()